{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:05:43Z","timestamp":1785708343045,"version":"3.56.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P-32064"],"award-info":[{"award-number":["P-32064"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P-34783"],"award-info":[{"award-number":["P-34783"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["SFB-F54"],"award-info":[{"award-number":["SFB-F54"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK122813"],"award-info":[{"award-number":["R01DK122813"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004061","name":"Austrian Central Bank","doi-asserted-by":"publisher","award":["OENB18450"],"award-info":[{"award-number":["OENB18450"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtha.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:45:42Z","timestamp":1769701542000},"page":"1840-1857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated levels of apolipoprotein C3 impair platelet function and reduce thrombosis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0550-4120","authenticated-orcid":false,"given":"Waltraud C.","family":"Schrottmaier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia B.","family":"Kral-Pointner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Mussbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Salzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Hochreiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Pirabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrun","family":"Badrnya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Volf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5670-5910","authenticated-orcid":false,"given":"Alice","family":"Assinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.01.004_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"Suppl M","key":"10.1016\/j.jtha.2026.01.004_bib2","first-page":"M8","article-title":"The emergence of triglycerides as a significant independent risk factor in coronary artery disease","volume":"19","author":"Assmann","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.01.004_bib3","doi-asserted-by":"crossref","first-page":"7B","DOI":"10.1016\/S0002-9149(98)00031-9","article-title":"Hypertriglyceridemia as a cardiovascular risk factor","volume":"81","author":"Austin","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0021-9150(03)00007-8","article-title":"Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease","volume":"167","author":"Lee","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jtha.2026.01.004_bib5","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1194\/jlr.M300253-JLR200","article-title":"Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease","volume":"44","author":"Olivieri","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jtha.2026.01.004_bib6","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1210\/jc.2003-032056","article-title":"Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity","volume":"89","author":"Cohn","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jtha.2026.01.004_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.81.2.470","article-title":"Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors","volume":"81","author":"Blankenhorn","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.01.004_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.90.1.42","article-title":"Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild\/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin","volume":"90","author":"Hodis","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.01.004_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0021-9150(95)05791-9","article-title":"Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease","volume":"122","author":"Koren","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jtha.2026.01.004_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacl.2015.05.002","article-title":"The risk of cardiovascular events with increased apolipoprotein CIII: a systematic review and meta-analysis","volume":"9","author":"Wyler von Ballmoos","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jtha.2026.01.004_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1538-7836.2009.03720.x","article-title":"Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation","volume":"8","author":"Olivieri","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.004_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/01.ATV.17.4.715","article-title":"The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial","volume":"17","author":"Alaupovic","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.004_bib13","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","article-title":"VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.01.004_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.ATV.0000066131.01313.EB","article-title":"LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients","volume":"23","author":"Lee","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.004_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0021-9150(03)00025-X","article-title":"Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders","volume":"168","author":"Onat","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jtha.2026.01.004_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI111711","article-title":"Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III","volume":"75","author":"Wang","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.01.004_bib17","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1021\/bi00733a026","article-title":"Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources","volume":"12","author":"Havel","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2026.01.004_bib18","first-page":"G805","article-title":"Influence of apolipoprotein E on soluble and heparin-immobilized hepatic lipase","volume":"252","author":"Landis","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jtha.2026.01.004_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0014-5793(76)80145-7","article-title":"Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase","volume":"65","author":"Kinnunen","year":"1976","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jtha.2026.01.004_bib20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.ATV.15.7.963","article-title":"Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E","volume":"15","author":"Clavey","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.004_bib21","doi-asserted-by":"crossref","first-page":"31348","DOI":"10.1074\/jbc.272.50.31348","article-title":"Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor","volume":"272","author":"Mann","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.01.004_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.106.622514","article-title":"Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells","volume":"114","author":"Kawakami","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.01.004_bib23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/eurheartj\/ehs271","article-title":"Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion","volume":"34","author":"Zheng","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.01.004_bib24","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.2337\/db09-0206","article-title":"ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan","volume":"58","author":"Hiukka","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jtha.2026.01.004_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/CIRCULATIONAHA.105.591743","article-title":"Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells","volume":"113","author":"Kawakami","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.01.004_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","article-title":"Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation","volume":"21","author":"Zewinger","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtha.2026.01.004_bib27","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI25482","article-title":"Modulation of atherosclerosis in mice by Toll-like receptor 2","volume":"115","author":"Mullick","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.01.004_bib28","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.0403249101","article-title":"Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E","volume":"101","author":"Michelsen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2026.01.004_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2147\/CLEP.S196266","article-title":"Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk","volume":"11","author":"Orsi","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jtha.2026.01.004_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000440","article-title":"Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele","volume":"2","author":"Olivieri","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2026.01.004_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010973","article-title":"Not just arterial damage: increased incidence of venous thromboembolic events in cardiovascular patients with elevated plasma levels of apolipoprotein CIII","volume":"8","author":"Olivieri","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2026.01.004_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1440-1711.2005.01314.x","article-title":"Evidence of Toll-like receptor molecules on human platelets","volume":"83","author":"Cognasse","year":"2005","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jtha.2026.01.004_bib33","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1182\/blood-2003-08-2804","article-title":"Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions","volume":"103","author":"Coppinger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.004_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2020.04.018","article-title":"Platelet-leukocyte interplay during vascular disease","volume":"307","author":"Schrottmaier","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jtha.2026.01.004_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.ATV.15.1.17","article-title":"Characterization of LDL and VLDL binding sites on human basophils and mast cells","volume":"15","author":"Virgolini","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.004_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/ATVBAHA.113.302919","article-title":"Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation","volume":"34","author":"Badrnya","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.004_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12471","article-title":"Fast live-cell conventional fluorophore nanoscopy with ImageJ through super-resolution radial fluctuations","volume":"7","author":"Gustafsson","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2026.01.004_bib38","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1021\/bi00644a004","article-title":"Lipid binding by fragments of apolipoprotein C-III-1 obtained by thrombin cleavage","volume":"16","author":"Sparrow","year":"1977","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2026.01.004_bib39","doi-asserted-by":"crossref","first-page":"17416","DOI":"10.1074\/jbc.M800756200","article-title":"Structure and dynamics of human apolipoprotein CIII","volume":"283","author":"Gangabadage","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.01.004_bib40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1538-7836.2005.01122.x","article-title":"Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress","volume":"3","author":"Bernardo","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.004_bib41","series-title":"Fundamentals of vascular biology","first-page":"145","article-title":"Mechanisms of hemostasis: contributions of platelets, coagulation factors, and the vessel wall","author":"Mussbacher","year":"2019"},{"key":"10.1016\/j.jtha.2026.01.004_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1432-1033.1994.00021.x","article-title":"Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition","volume":"225","author":"Horstrup","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jtha.2026.01.004_bib43","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0022-2275(20)37413-7","article-title":"Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake","volume":"38","author":"Xu","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jtha.2026.01.004_bib44","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1194\/jlr.M200322-JLR200","article-title":"ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan","volume":"43","author":"Olin-Lewis","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jtha.2026.01.004_bib45","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/ATVBAHA.119.312723","article-title":"ApoC-III glycoforms are differentially cleared by hepatic TRL (triglyceride-rich lipoprotein) receptors","volume":"39","author":"Kegulian","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.004_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.ATV.0000249620.68705.0d","article-title":"Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C\u03b1-mediated nuclear factor-\u03baB activation","volume":"27","author":"Kawakami","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.004_bib47","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2337\/diabetes.52.5.1248","article-title":"A novel role for CD36 in VLDL-enhanced platelet activation","volume":"52","author":"Englyst","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jtha.2026.01.004_bib48","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1038\/s41467-018-05806-0","article-title":"Apolipoprotein A-IV binds \u03b1IIb\u03b23 integrin and inhibits thrombosis","volume":"9","author":"Xu","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2026.01.004_bib49","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3324\/haematol.2022.282136","article-title":"The relative importance of platelet integrins in hemostasis, thrombosis and beyond","volume":"108","author":"Janus-Bell","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.01.004_bib50","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/eurheartj\/ehab820","article-title":"Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk","volume":"43","author":"Tardif","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.01.004_bib51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and triglyceride levels in familial chylomicronemia syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.004_bib52","article-title":"Roles of G proteins and their GTPase-activating proteins in platelets","volume":"44","author":"O\u2019Donoghue","year":"2024","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jtha.2026.01.004_bib53","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1160\/TH16-02-0096","article-title":"Integrin-\u03b1IIb\u03b23-mediated outside-in signalling activates a negative feedback pathway to suppress platelet activation","volume":"116","author":"Dai","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.004_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.advenzreg.2010.09.011","article-title":"Regulation and roles of PI3K\u03b2, a major actor in platelet signaling and functions","volume":"51","author":"Gratacap","year":"2011","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.jtha.2026.01.004_bib55","first-page":"255","article-title":"PI3K isoform signalling in platelets","volume":"436","author":"Schrottmaier","year":"2022","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jtha.2026.01.004_bib56","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1160\/TH12-03-0206","article-title":"Platelets directly enhance neutrophil transmigration in response to oxidised low-density lipoprotein","volume":"108","author":"Badrnya","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.004_bib57","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1073\/pnas.76.11.5645","article-title":"Lateral mobility of an amphipathic apolipoprotein, ApoC-III, bound to phosphatidylcholine bilayers with and without cholesterol","volume":"76","author":"Vaz","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2026.01.004_bib58","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/01.ATV.0000116219.09040.8c","article-title":"Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids","volume":"24","author":"Kr\u00f6tz","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.004_bib59","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/09537104.2021.1904135","article-title":"Why do platelets express K+ channels?","volume":"32","author":"Wright","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2026.01.004_bib60","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1538-7836.2012.04837.x","article-title":"The unique contribution of ion channels to platelet and megakaryocyte function","volume":"10","author":"Mahaut-Smith","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.004_bib61","doi-asserted-by":"crossref","first-page":"30817","DOI":"10.1074\/jbc.M005066200","article-title":"Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actin","volume":"275","author":"Harbeck","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.01.004_bib62","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1242\/jcs.044537","article-title":"Differential VASP phosphorylation controls remodeling of the actin cytoskeleton","volume":"122","author":"Benz","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jtha.2026.01.004_bib63","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1038\/s41467-020-19515-0","article-title":"Vascular surveillance by haptotactic blood platelets in inflammation and infection","volume":"11","author":"Nicolai","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2026.01.004_bib64","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.cell.2017.11.001","article-title":"Migrating platelets are mechano-scavengers that collect and bundle bacteria","volume":"171","author":"Gaertner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2026.01.004_bib65","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.atherosclerosis.2014.07.008","article-title":"Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides","volume":"236","author":"Prenner","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jtha.2026.01.004_bib66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijcard.2020.08.030","article-title":"The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular disease","volume":"322","author":"Heidemann","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtha.2026.01.004_bib67","first-page":"898","article-title":"Plasma lipoprotein pattern and decreased platelet function in type V hyperlipoproteinemia","volume":"21","author":"Aviram","year":"1985","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.jtha.2026.01.004_bib68","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1053\/meta.2000.6742","article-title":"Platelet function in patients with familial hypertriglyceridemia: evidence that platelet reactivity is modulated by apolipoprotein E content of very-low-density lipoprotein particles","volume":"49","author":"Pedre\u00f1o","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.jtha.2026.01.004_bib69","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-2275(20)37642-2","article-title":"Apolipoprotein A-I\/C-III\/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III","volume":"37","author":"Dallinga-Thie","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jtha.2026.01.004_bib70","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.ATV.0000054194.78240.45","article-title":"Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice","volume":"23","author":"Pennacchio","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.004_bib71","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/09537104.2022.2078488","article-title":"elevated in trauma patients, inhibits platelet activation and decreases clot strength","volume":"33","author":"Jones","year":"2022","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2026.01.004_bib72","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/blood-2014-09-599530","article-title":"High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion","volume":"127","author":"Chung","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.004_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2025.101343","article-title":"Apolipoproteins in circulation: At the interface of thrombosis and stroke initiation","volume":"100","author":"Etuze","year":"2025","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jtha.2026.01.004_bib74","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0735-1097(00)00775-0","article-title":"Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease","volume":"36","author":"Kronenberg","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2026.01.004_bib75","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/eurjpc\/zwac263","article-title":"U-shaped relationship between apolipoprotein A1 levels and mortality risk in men and women","volume":"30","author":"Faaborg-Andersen","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jtha.2026.01.004_bib76","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1055\/s-0037-1613100","article-title":"Platelet activation by the apoB\/E receptor-binding domain of LDL","volume":"87","author":"Relou","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.004_bib77","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1055\/s-0037-1615654","article-title":"Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation","volume":"85","author":"Mart\u00ednez","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.004_bib78","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1160\/TH13-12-1026","article-title":"Apolipoprotein B100 danger-associated signal 1 (ApoBDS-1) triggers platelet activation and boosts platelet-leukocyte proinflammatory responses","volume":"112","author":"Assinger","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.004_bib79","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41590-023-01423-2","article-title":"Apolipoprotein C3 induces inflammasome activation only in its delipidated form","volume":"24","author":"Hsu","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtha.2026.01.004_bib80","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0022-2275(20)31969-6","article-title":"Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr","volume":"41","author":"Liu","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jtha.2026.01.004_bib81","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0167-4838(99)00009-6","article-title":"Kinetics and mechanism of exchange of apolipoprotein C-III molecules from very low density lipoprotein particles","volume":"1430","author":"Boyle","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jtha.2026.01.004_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12140","article-title":"Formation of a protein corona on the surface of extracellular vesicles in blood plasma","volume":"10","author":"T\u00f3th","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jtha.2026.01.004_bib83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1007038129481","article-title":"Apolipoprotein C-III can specifically bind to hepatic plasma membranes","volume":"207","author":"Fang","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jtha.2026.01.004_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100475","article-title":"Apolipoprotein C3: form begets function","volume":"65","author":"Bornfeldt","year":"2024","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jtha.2026.01.004_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2021.104398","article-title":"Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects","volume":"251","author":"Rodr\u00edguez","year":"2022","journal-title":"J Proteomics"},{"key":"10.1016\/j.jtha.2026.01.004_bib86","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/ATVBAHA.123.319035","article-title":"Apo CIII proteoforms, plasma lipids, and cardiovascular risk in MESA","volume":"43","author":"Sinari","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.004_bib87","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1172\/JCI110532","article-title":"An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III","volume":"69","author":"Holdsworth","year":"1982","journal-title":"J Clin Invest"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:57:15Z","timestamp":1783972635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626000462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1538783626000462"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.004","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated levels of apolipoprotein C3 impair platelet function and reduce thrombosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}